Microbot Medical Inc. (MBOT): Cost of Revenue

Annual figures by period end, from SEC filings.

Partial revenue. In this company's filings, operating income for the year ended 2015-12-31 is larger than reported revenue. The revenue it tags covers only part of its income (banks and REITs often tag only fee income this way, leaving out interest or rent), so it is not the company's whole top line. Margins on it are not computed, and it is left out of revenue rankings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2013-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$316.6K
Year ended 2013-12-31
+23.4%
3-year compound annual growth
2009-12-31: $261.4K2010-12-31: $168.4K2011-12-31: $214.8K2012-12-31: $263.2K2013-12-31: $316.6K$316.6K
2009-12-31 Cost of Revenue (USD) 2013-12-31
Period endedCost of RevenueChange YoYSource filing
2013-12-31$316.6K+20.3%2014-03-13, From 2013-01-01
2012-12-31$263.2K+22.5%2014-03-13, From 2012-01-01
2011-12-31$214.8K+27.5%2014-03-13, From 2011-01-01
2010-12-31$168.4K-35.6%2013-03-21, From 2010-01-01
2009-12-31$261.4Kn/a2012-03-15, From 2009-01-01